Compass Therapeutics Stock Price History

CMPX Stock  USD 1.50  0.01  0.67%   
If you're considering investing in Compass Stock, it is important to understand the factors that can impact its price. As of today, the current price of Compass Therapeutics stands at 1.50, as last reported on the 26th of November, with the highest price reaching 1.62 and the lowest price hitting 1.50 during the day. Compass Therapeutics appears to be very risky, given 3 months investment horizon. Compass Therapeutics secures Sharpe Ratio (or Efficiency) of 0.0932, which signifies that the company had a 0.0932% return per unit of risk over the last 3 months. By analyzing Compass Therapeutics' technical indicators, you can evaluate if the expected return of 0.52% is justified by implied risk. Please makes use of Compass Therapeutics' Mean Deviation of 4.14, risk adjusted performance of 0.0799, and Downside Deviation of 4.66 to double-check if our risk estimates are consistent with your expectations.
  
Compass Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = 0.0932

Best PortfolioBest Equity
Good Returns
Average Returns
Small ReturnsCMPX
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns

Estimated Market Risk

 5.52
  actual daily
49
51% of assets are more volatile

Expected Return

 0.52
  actual daily
10
90% of assets have higher returns

Risk-Adjusted Return

 0.09
  actual daily
7
93% of assets perform better
Based on monthly moving average Compass Therapeutics is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Compass Therapeutics by adding it to a well-diversified portfolio.

Compass Therapeutics Stock Price History Chart

There are several ways to analyze Compass Stock price data. The simplest method is using a basic Compass candlestick price chart, which shows Compass Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceOctober 11, 20241.98
Lowest PriceNovember 18, 20241.35

Compass Therapeutics November 26, 2024 Stock Price Synopsis

Various analyses of Compass Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Compass Stock. It can be used to describe the percentage change in the price of Compass Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Compass Stock.
Compass Therapeutics Price Daily Balance Of Power 0.08 
Compass Therapeutics Price Rate Of Daily Change 1.01 
Compass Therapeutics Price Action Indicator(0.06)

Compass Therapeutics November 26, 2024 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Compass Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Compass Therapeutics intraday prices and daily technical indicators to check the level of noise trading in Compass Stock and then apply it to test your longer-term investment strategies against Compass.

Compass Stock Price History Data

OpenHighLowCloseVolume
11/26/2024
 1.55  1.62  1.50  1.50 
11/25/2024 1.55  1.62  1.50  1.50  527,796 
11/22/2024 1.40  1.53  1.36  1.49  540,044 
11/21/2024 1.37  1.41  1.34  1.38  348,932 
11/20/2024 1.41  1.46  1.36  1.37  303,745 
11/19/2024 1.37  1.42  1.31  1.42  419,025 
11/18/2024 1.37  1.38  1.27  1.35  665,963 
11/15/2024 1.62  1.62  1.34  1.38  1,348,934 
11/14/2024 1.72  1.75  1.58  1.59  669,087 
11/13/2024 1.83  1.85  1.67  1.69  455,750 
11/12/2024 1.90  1.94  1.77  1.79  359,426 
11/11/2024 1.87  2.00  1.81  1.90  543,504 
11/08/2024 1.87  1.87  1.79  1.80  560,996 
11/07/2024 1.85  1.91  1.74  1.84  520,037 
11/06/2024 1.85  1.90  1.81  1.83  1,238,891 
11/05/2024 1.70  1.80  1.68  1.75  313,274 
11/04/2024 1.72  1.78  1.65  1.70  413,572 
11/01/2024 1.67  1.76  1.66  1.70  359,137 
10/31/2024 1.71  1.71  1.58  1.64  516,018 
10/30/2024 1.73  1.83  1.69  1.71  377,620 
10/29/2024 1.66  1.73  1.65  1.70  400,332 
10/28/2024 1.69  1.80  1.65  1.68  283,853 
10/25/2024 1.78  1.79  1.71  1.72  269,345 
10/24/2024 1.84  1.85  1.73  1.76  321,824 
10/23/2024 1.82  1.84  1.74  1.79  302,817 
10/22/2024 1.83  1.87  1.80  1.83  746,518 
10/21/2024 1.90  1.94  1.84  1.85  264,339 
10/18/2024 1.91  1.92  1.85  1.86  198,250 
10/17/2024 1.92  1.97  1.81  1.91  2,218,530 
10/16/2024 1.92  1.99  1.91  1.98  249,735 
10/15/2024 1.96  1.99  1.85  1.91  274,896 
10/14/2024 2.01  2.08  1.83  1.97  700,415 
10/11/2024 1.72  1.98  1.72  1.98  545,345 
10/10/2024 1.62  1.76  1.62  1.73  411,444 
10/09/2024 1.71  1.78  1.60  1.61  398,791 
10/08/2024 1.99  1.99  1.72  1.73  393,119 
10/07/2024 1.93  1.95  1.89  1.94  293,016 
10/04/2024 1.95  1.96  1.82  1.93  297,550 
10/03/2024 1.88  1.93  1.81  1.90  271,821 
10/02/2024 1.89  1.93  1.77  1.92  626,918 
10/01/2024 1.85  1.95  1.80  1.90  756,370 
09/30/2024 1.99  1.99  1.72  1.84  433,782 
09/27/2024 1.82  1.93  1.76  1.88  300,768 
09/26/2024 1.70  1.82  1.67  1.81  337,906 
09/25/2024 1.69  1.75  1.61  1.73  429,584 
09/24/2024 1.65  1.73  1.58  1.71  625,351 
09/23/2024 1.70  1.72  1.58  1.59  331,061 
09/20/2024 1.71  1.72  1.61  1.66  1,123,660 
09/19/2024 1.71  1.79  1.70  1.73  312,367 
09/18/2024 1.75  1.75  1.63  1.63  326,435 
09/17/2024 1.75  1.78  1.62  1.66  629,483 
09/16/2024 1.75  1.86  1.61  1.71  558,778 
09/13/2024 1.59  1.65  1.52  1.65  254,163 
09/12/2024 1.50  1.56  1.50  1.54  167,000 
09/11/2024 1.57  1.58  1.50  1.50  204,236 
09/10/2024 1.64  1.65  1.52  1.58  273,687 
09/09/2024 1.42  1.64  1.42  1.59  387,470 
09/06/2024 1.50  1.50  1.43  1.43  265,583 
09/05/2024 1.54  1.61  1.48  1.49  726,306 
09/04/2024 1.51  1.59  1.50  1.54  372,952 
09/03/2024 1.59  1.80  1.49  1.51  1,100,845 

About Compass Therapeutics Stock history

Compass Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Compass is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Compass Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Compass Therapeutics stock prices may prove useful in developing a viable investing in Compass Therapeutics
Compass Therapeutics, Inc., a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases. The company was founded in 2014 and is headquartered in Boston, Massachusetts. Compass Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 24 people.

Compass Therapeutics Stock Technical Analysis

Compass Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Compass Therapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Compass Therapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Global Markets Map Now

   

Global Markets Map

Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
All  Next Launch Module

Compass Therapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Compass Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Compass Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Compass to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Compass Stock Analysis

When running Compass Therapeutics' price analysis, check to measure Compass Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Compass Therapeutics is operating at the current time. Most of Compass Therapeutics' value examination focuses on studying past and present price action to predict the probability of Compass Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Compass Therapeutics' price. Additionally, you may evaluate how the addition of Compass Therapeutics to your portfolios can decrease your overall portfolio volatility.